Ribatti D, Vacca A
Istituto di Anatomia Umana Normale, di Istologia ed Embriologia, Università degli Studi di Bari.
Ann Ital Med Int. 1994 Apr-Jun;9(2):92-5.
Angiogenesis is a fundamental biological process by which new capillary blood vessels are formed. It is essential in many physiological conditions, such as embryonic development, ovulation and wound repair, and pathological ones, such as arthritis, diabetic retinopathy, and tumours. Solid tumours have angiogenesis capacity, and tumour growth and metastasis are angiogenesis-dependent. Neoplastic cell populations can grow to form a clinically evident tumour only if the host produces a vascular network sufficient to sustain tumour growth. Furthermore, the new blood vessels provide a gateway for tumour cells to enter the circulation and metastasize to distant sites. Tumour angiogenesis is essentially mediated by angiogenic molecules elaborated by tumour cells. We review here the most important literature on this topic and emphasize the crucial and paradigmatic role of this biological process and its relevance in a possible anti-angiogenic therapeutic approach to the treatment of solid tumours.
血管生成是一个基本的生物学过程,通过该过程形成新的毛细血管。它在许多生理状况下至关重要,如胚胎发育、排卵和伤口修复,以及在诸如关节炎、糖尿病视网膜病变和肿瘤等病理状况下也很关键。实体瘤具有血管生成能力,肿瘤生长和转移依赖于血管生成。只有宿主产生足以维持肿瘤生长的血管网络时,肿瘤细胞群体才能生长形成临床上可察觉的肿瘤。此外,新血管为肿瘤细胞进入循环并转移至远处部位提供了途径。肿瘤血管生成主要由肿瘤细胞分泌的血管生成分子介导。我们在此回顾关于该主题的最重要文献,并强调这一生物学过程的关键和典范作用及其在实体瘤治疗中可能的抗血管生成治疗方法中的相关性。